Please note that the doses mentioned here are not recognised in France by the regulatory body for market authorization.
However, it is possible to use these doses depending on the patient's specific clinical situation. The international literature recognizes the value of using these doses in specific situations.
However, this prescription must be justified in the medical records, and a risk-benefit analysis should be carried out.
These doses are adminstered under the responsibility of the prescriber.
The authors of this app accept no responsibility under any circumstances.